Effects of Phenylacetate on Cells from Patients with B-Chronic Lymphocytic Leukemia

References

• Gazitt Y., Polliack A. Phorbol ester induction of plasmacytoid and hairy-cell features in B-type lymphocytic leukemia: The relation to B-cell differentiation and maturation. Blood Cells 1987; 12: 413–436
   PubMedGoogle Scholar
• Al-Katib A., Wang C. Y., McKenzie S., Clarkson B. D., Koziner B. Phorbol ester induced hairy cell features in chronic lymphocytic leukemia cells in vitro. Am. J. Hematol. 1992; 40: 264–269
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Gignac S. M., Jones R. A., Scott C. S., Pettit G. R., Hoffbrand A. V. Bryostatin I induces differentiation of B-chronic lymphocytic leukemia cells. Blood 1989; 74: 1747–1757
   PubMed Web of Science ®Google Scholar
• Samid D., Yeh T. J., Shack S. Interferon in combination with anti-tumourigenic phenyl derivatives: potentiation of IFNgm activity in vitro. Br. J. Haematol. 1991; 79(1)81–83
   PubMed Web of Science ®Google Scholar
• Samid D., Shack S., Sherman L. T. Phenyl-acetate: A novel nontoxic inducer of tumor cell differentiation. Cancer Res. 1992; 52: 1988–1992
   PubMed Web of Science ®Google Scholar
• Samid D., Yeh A., Prasanna P. Induction of erythroid differentiation and fetal hemoglobin production in human leukemia cells treated with phenylacetate. Blood 1992; 80: 1576–1581
   PubMed Web of Science ®Google Scholar
• Newsholme E. A., Crabtree B., Ardawi M. S. M. Glutamine metabolism in lymphocytes: Its biochemical, physiological and clinical importance. Q. J. Exp. Physiol. 1985; 70: 473–489
   PubMed Web of Science ®Google Scholar
• Freshney R. I. Culture of animal cells 2nd ed. Alan R. Liss, New York 1987; 246–247
   Google Scholar
• Devlin T. M. Alternative reactions for elimination of excess nitrogen. 11.6; Textbook of Biochemistry 3rd ed. Wiley-Liss, New York, NY 1992; 480–603
   Google Scholar
• Bulus N., Cersosimo E., Ghisham F., Abumrad N. N. Physiologic importance of glutamine. Metabolism 1989; 38(Suppl. 1)1
   PubMed Web of Science ®Google Scholar
• Newsholme E. A., Crabtree B., Ardawi M. S. M. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci. Rep. 1985; 5: 393–400
   PubMedGoogle Scholar
• Ardawi M. S. M. Glutamine and glucose metabolism in human peripheral lymphocytes. Metabolism 1988; 37: 99–103
   PubMed Web of Science ®Google Scholar
• Parry-Billings M., Evans J., Calder P. C., Newsholme E. A. Does glutamine contribute to immunosuppression after major burns?. Lancet 1990; 336: 523–525
   PubMed Web of Science ®Google Scholar
• Kafkewitz D., Bendich A. Enzyme induced as-paragine and glutamine depletion and immune system function. Am. J. Clin. Nutrition 1983; 37: 1025–1030
   PubMed Web of Science ®Google Scholar
• Raivio K. O., Andersson L. C. Glutamine requirements for purine metabolism in leukemic lymphoblast. Leukemia Res. 1982; 6: 111–115
   PubMed Web of Science ®Google Scholar
• Kitoh T., Kubota M., Takimoto T., Hashimoto H., Shim-Izu T., Sano H., Akiyama Y., Mikawa H. Metabolic basis for differential glutamine requirements of human leukemia cell lines. J. Cell. Physiol. 1990; 143: 150–158
   PubMed Web of Science ®Google Scholar
• Brand K., Fekl W., von Hintzenstern J., Langer K., Luppa P., Schoerner C. Metabolism of glutamine in lymphocytes. Metabolism 1989; 38(Suppl. 1)29–33
   PubMed Web of Science ®Google Scholar
• Schrek R., Holcenberg J. S., Batra K. V., Roberts J., Dolowy W. C. Effect of asparagine and glutamine deficiency on normal and leukemic cells. J. Natl. Can. Inst. 1973; 51: 1103–1107
   PubMed Web of Science ®Google Scholar
• Schrek R., Holcenberg J. S., Roberts J., Dolowy W. C. In vitro cytocidal effect of L-glutaminase on leukemic lymphocytes. Nature 1971; 232: 265
   PubMed Web of Science ®Google Scholar
• Spiers A. S. D., Wade H. E. Achromobacter L-glutaminase and L-asparaginase: Human pharmacology, toxicity, and activity in acute leukemias. Cancer Treat. Rep. 1979; 63: 1019–1024
   PubMedGoogle Scholar
• Holcenberg J. S., Camitta G. M., Borella L. D., Ring B. J. Phase I study of succinylated Acinetobacter L-glutaminase-L-asparaginase. Cancer Treat. Rep. 1979; 63: 1025–1030
   PubMedGoogle Scholar
• Ahluwalia G. S., Grem J. L., Hao Z., Cooney D. A. Metabolism and action of amino acid analog anti-cancer agents. Pharmac. Ther. 1990; 46: 243–271
   PubMed Web of Science ®Google Scholar
• Brusilow S. W., Danney M., Waber L. J., Batshaw M., Burton B., Levitsky L., Roth K., McKeethren C., Ward J. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N. Engl. J. Med. 1984; 310: 1630–1634
   PubMed Web of Science ®Google Scholar
• Sherwin C. P., Kennard K. S. Toxicity of phenylacetic acid. J. Biologic. Chem. 1919; 40: 259–264
   Google Scholar
• Ambrose A. M., Power F. W., Sherwin C. P. Further studies on the detoxification of phenylacetic acid. J. Biologic. Chem. 1933; 101: 669–675
   Google Scholar
• Brusilow S. W. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr. Res. 1991; 29: 147–150
   PubMed Web of Science ®Google Scholar
• Maestri N. E., Hauser E. R., Bartholomew D., Brusilow S. W. Prospective treatment of urea cycle disorders. J. Pediatr. 1991; 119: 923–928
   PubMed Web of Science ®Google Scholar
• Dover G. J., Brusilow S. W., Samid D. Increased fetal hemoglobin in patients receiving sodium 4-phen-ylbutyrate. N. Engl. J. Med. 1992; 327: 569–570
   PubMed Web of Science ®Google Scholar
• Samid D., Shack S., Myers C. E. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J. Clin. Invest. 1993; 91: 2288–2295
   PubMed Web of Science ®Google Scholar
• Hanson J. A., Bean E. A., Nute S. R., Moore J. L. A novel dye exclusion assay for measurement of cell response following in vitro exposure to radiation or drugs. Leukemia Res. 1989; 13: 943–947
   PubMed Web of Science ®Google Scholar